Is biotech on the rebound?

Home
News

Wednesday 02, September 2009 by

Is biotech on the rebound?

Investors accurately forecasted the rebound of the biotechnology industry, but underestimated the degree to which positive clinical trial data would drive the sector higher, according to findings from an investor perception study by the Biotechnology Industry Organization (BIO) and Thomson Reuters.

This content is available to registered users only.
Please click here to register/login.

Features & Analyses

Economics IMF updates on Iraq economy

Recent macroeconomic developments have been broadly positive in Iraq. Economic growth in Iraq reached 8.4 per cent in 2012 and… read more

Islamic Finance Barclays upbeat about Qatari banking sector
Investments Global accountants stick to plans for leases on balance sheets
Investment Banking Obligations and responsibilities of investment managers under draft SCA…
SME Finance Family businesses at the forefront of Middle East’s growth
see all archive